{
 "PrintNo":"A635","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2023-01-11T09:14:50.223598Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Higher Education",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-01-03","Committee":"Higher Education"}],
 "Actions":[
  {"Text":"REFERRED TO HIGHER EDUCATION","Date":"2023-01-11","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HIGHER EDUCATION","Date":"2024-01-03","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":460,"Name":"Jeffrion Aubry","Short":"AUBRY"}],
 "Title":"Prohibits a pharmacist from substituting any anti-epileptic drug for a prescribed anti-epileptic drug without the informed consent of the prescriber and patient",
 "Summary":"Prohibits a pharmacist from substituting any anti-epileptic drug for the prescribed anti-epileptic drug without notification of and the informed consent of the prescriber and patient or such patient's parent, guardian or spouse.",
 "LawSection":"Public Health Law","LawCode":"Add ยง3346, Pub Health L; amd ยง6816-a, Ed L",
 "ActClause":"AN ACT to amend the public health law and the education law, in relation to requiring notification of and the informed consent of the prescriber and the patient prior to the substitution of a prescribed anti-epileptic drug",
 "PreviousVersions":["A9303-2007","A3528-2009","A6574-2011","A3062-2013","A2991-2015","A3719-2017","A3982-2019","A1982-2021"]
}